The largest transplant practice of its kind in the southeastern United States, Moffitt Cancer Center’s Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI) Program provides patients with comprehensive diagnostic, donor matching, transplant as well as chimeric antigen receptor or CAR T cell therapy, other immunotherapy, and supportive care services in a single location.

hospital team for blood and bone marrow transplant

Our BMT and cellular immunotherapy specialists cater to patients with leukemia, multiple myeloma, lymphoma, aplastic anemia, myelodysplastic syndrome (MDS), myelofibrosis, sickle cell anemia and certain solid tumors such as germ cell tumor. Moffitt’s patients benefit from the expertise of physicians who focus exclusively on the treatment of hematological conditions with transplant and CAR T, and collaborate to develop individualized treatment plans. It is this level of attention – combined with our advanced treatments and compassionate care – that leads to better outcomes and improved quality of life for our patients.

A key distinguishing factor of Moffitt’s BMT CI program is the talented physicians who make up our team. Here, experienced medical oncologists, hematologists, pathologists, psychologists and other specialists such as social workers provide a full spectrum of treatment and supportive care to our patients.

BMT information for referring physicians

There are several reasons why physicians throughout the nation refer patients to Moffitt’s Blood and Marrow Transplant and Cellular Immunotherapy Program (BMT CI). For example, Moffitt is:

A National Marrow Donor Program (NMDP) transplant and collection center
Fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT)
Among a select few providers to offer bone marrow transplantation (BMT) to adults ages 70 and older
One of only a handful of centers in the nation performing a high volume of transplants with outcomes exceeding expected survival
A core member of the BMT Clinical Trials Network (BMT CTN) that spearheads an ambitious clinical trials program through which our patients can receive the latest treatment breakthroughs
A center performing transplants from various donor types including related haploidentical and mismatched unrelated donors
A center specialized in the treatment of patients with severe and refractory graft-versus-host disease (GVHD)
A center conducting a high volume of CAR T cell therapy for lymphoma, myeloma and leukemia under the dedicated Immune Cell Therapy (ICE-T) service, and has led many pivotal national clinical trials for CAR T cell therapy
A center with a dedicated survivorship program for BMT and CAR T recipients

To refer a patient to Moffitt’s BMT and cellular immunotherapy specialists, complete our online form or contact a physician liaison. We place emphasis on minimizing referral times and aim to respond to all referrals on the same business day that they are received.

Medically reviewed by Taiga Nishihori, MD, Blood and Marrow Transplant and Cellular Immunotherapy Program

BMT and CI Leadership

Frederick Locke, MD

Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy

Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Title

Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Nelli Bejanyan, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Title

Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Blood and Marrow Transplant & Cellular Immunotherapy at Magnolia Campus

Meet the providers located in Tampa, FL.

Melissa Alsina, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, Multiple Myeloma-Plasma Cell Tumor

4.9 (265)

Claudio Anasetti, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS)

Nelli Bejanyan, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Title

Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, MDS, Myelodysplastic Syndromes (MDS)

Kaaron Benson, MD

Program

Pathology

Specialty

Pathology

Cancer Focus

Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

Margaret Booth-Jones, PhD

Program

Supportive Care Medicine

Specialty

Clinical Psychology

5 (157)

Omar Castaneda Puglianini, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Medical Oncology

Cancer Focus

Multiple Myeloma-Plasma Cell Tumor

4.9 (47)

Hany Elmariah, MD, MS

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, MDS, Myelodysplastic Syndromes (MDS)

5 (45)

Rawan Faramand, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, MDS, Myelodysplastic Syndromes (MDS)

4.9 (56)

Ciara Freeman, MD, PhD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Medical Oncology

4.9 (62)

Doris Hansen, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

5 (21)

Michael Jain, MD, PhD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

4.9 (52)

Farhad Khimani, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

4.9 (33)

Aleksandr Lazaryan, MD, MPH, PhD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Hodgkin Lymphoma, Non-Hodgkin Lymphoma

5 (36)

Hien Liu, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Hodgkin Lymphoma, Non-Hodgkin Lymphoma

4.9 (62)

Frederick Locke, MD

Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy

Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Title

Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

Sayeef Mirza, MD, MPH

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Hematology/Oncology

Cancer Focus

Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

Asmita Mishra, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, MDS, Myelodysplastic Syndromes (MDS)

4.9 (29)

Michael Nieder, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Taiga Nishihori, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma, Testicular Cancer

4.9 (67)

Jose Ochoa-Bayona, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, Multiple Myeloma-Plasma Cell Tumor, Ovarian Cancer, Testicular Cancer

4.9 (46)

Lia Perez, MD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Hodgkin Lymphoma, Leukemia, MDS, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

4.9 (30)

Fabiana Perna, MD, PhD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Hematology

Cancer Focus

Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

Joseph Pidala, MD, PhD

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Cancer Focus

Leukemia, MDS, Myelodysplastic Syndromes (MDS)

5 (31)

Ramon Sandin, MD, MS

Program

Pathology

Specialty

Pathology

Cancer Focus

Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

Karla Adams, PA-C

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Danielle Baratta, PA-C

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Blood and Marrow Transplant and Cellular Immunotherapy

Chrissy Copponex, APRN

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Marian Dam, APRN

Program

Blood and Marrow Transplant and Cellular Immunotherapy

KC Garfield, APRN

Program

Blood and Marrow Transplant and Cellular Immunotherapy

William Giove, PA

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Kristy Harvey, PA-C

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Erik Hollers, PA-C

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Nikita Hope, APRN

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Jessica Marin, PA-C

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Hematology/Oncology

Cancer Focus

Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

Meredith Markey, PA-C

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Catherine Quealy, APRN

Program

Blood and Marrow Transplant and Cellular Immunotherapy

Specialty

Hematology/Oncology

Cancer Focus

Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

Bone and Marrow Transplant & Cellular Immunotherapy at Memorial Health

Meet the providers located in Pembroke Pines, FL.

Yehuda Deutsch, MD

Program

Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Specialty

Hematology/Oncology

Cancer Focus

Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

Hugo Fernandez, MD

Department Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Program Lead, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Program

Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Title

Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Specialty

Medical Oncology

Cancer Focus

Leukemia, Myelodysplastic Syndromes (MDS)

Jose Sandoval Sus, MD

Program

Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Specialty

Hematology/Oncology

Cancer Focus

Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

BMT and Cellular Immunotherapy Program

BMT and Cellular Immunotherapy Team

BMT information for referring physicians

Cambiar el idioma